Navigation Links
US Drug Watchdog Now Urges Women Who Had A Out Of The Blue Heart Attack Or Stroke Who Were Also Using Yaz or Yasmin Birth Control Pills To Call The Johnson Law Group ASAP
Date:1/17/2013

(PRWEB) January 17, 2013

The US Drug Watchdog says, “We are urging close friends, family members, or mothers of younger women who had an out the blue heart attack, a stroke, a pulmonary embolism, developed a blood clot or other severe medical complications to contact the Johnson Law Group immediately, if the victim was also using the birth control pills called Yaz, Yasmin, or generic version Ocella." As a background, in September of 2009, the US FDA released a warning letter sent to Bayer Pharmaceuticals over Yaz & Yasmin. The letter indicates that the drug maker hid out-of-specification test results for key ingredients in the birth control pills. The US Drug Watchdog says, "If you, a friend, or a loved one was using birth control pills called Yaz, Yasmin, or their generic version Ocella, and severe side effects occurred, such a pulmonary embolism, a heart attack, a stroke, or other severe medical conditions please contact The Johnson Law Group immediately at 1-800-996-9900. http://www.johnsonlawgroup.com/

Possible Side Effects Yaz/Yasmin Birth Control Pills

  • Yaz / Yasmin Stroke or Heart attack
  • Yaz / Yasmin Pulmonary Embolism
  • Yaz / Yasmin Deep Vein Thrombosis
  • Yaz / Yasmin Blood Clots
  • Sudden Death from Yaz or Yasmin

The US Drug Watchdog says, "One of the biggest problems we have with respect to our drug initiative work, is the average US consumer never hears about a drug recall, or serious side effects related to a specific drug's use. We are attempting to change this very sad fact with aggressive initiatives focused on increasing public awareness, and suggesting possible help for victims. In the instances of the birth control pills called Yaz. Yasmin, or their generic version Ocella we doubt a young woman would ever
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. US Drug Watchdog Now Offers Victims Of A Transvaginal Mesh Product Failure The Names Of The Best Possible Women Lawyers To Help Natiowide
2. US Drug Watchdog Now Offers Metal on Metal Hip Implant Recipients With Elevated Metal Levels the Names of the Best Attorneys-Get Compensated
3. US Drug Watchdog Now Urges Loved Ones Of Diabetics Diagnosed with Bladder Cancer To Call The Johnson Law Group If The Loved One Also Used the Diabetes Drug Called Actos
4. US Drug Watchdog Now Urges Transvaginal Mesh Product Failure Victims To Call Them For The Names Of The Best Women Attorneys To Help Them With A Staggering Dilemma
5. US Drug Watchdog Now Offers To Help All DePuy Pinnacle All Metal Hip Implant Recipients get to the Best Law Firms If A Blood Test Reveals Elevated Metal Levels
6. US Drug Watchdog Now Urges Victims of a Transvaginal Mesh Product Failure To Get Some Meaningful Help From Women Attorneys Who Understand This Horrific Mess and the Costs
7. US Drug Watchdog Now Urges All 500,000 US Recipients Of A Metal on Metal Hip Implant To Get A Blood Test for Elevated Levels Of Cobalt and Chromium
8. US Drug Watchdog Now Urges Victims of a Unsuccessful Transvaginal Mesh Product Revision Surgery to Call Them for the Names of the Best Possible Lawyers - Who Are All Women
9. US Drug Watchdog Now Puts a New Emphasis on DePuy Pinnacle Hip Implant Recipients and They Urge Them to Get a Blood Test for Elevated Metals Levels
10. US Drug Watchdog Now Urges Families Of Diabetics Diagnosed with Bladder Cancer To Call The Johnson Law Group If They Used the Diabetes Drug Called Actos
11. US Drug Watchdog Is Now Open All Weekends To Help Victims Of A Transvaginal Mesh Product Failures With A Service That Includes Naming Top Attorneys--Who Are All Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2014)... from UNC,s Frank Porter Graham Child Development Institute (FPG) ... for life after high school. , "Public high schools ... adolescents with autismand for their families," said FPG director ... unemployment and few social ties after school ends." , ... schools work hard to achieve beneficial results for students ...
(Date:3/5/2014)... to cancer immunotherapy strategies designed to induce ... may provide a new and cost-effective weapon against ... cancer and mesothelioma. Investigators from the Massachusetts General ... the Journal of Hematology & Oncology ... targeting a tumor-cell-surface antigen with another protein that ...
(Date:3/3/2014)... do not report symptoms of traumatic brain injury (TBI) ... comparable to veterans with TBI, according to researchers at ... , The findings, published in the Journal ... suggest that a lack of clear TBI symptoms following ... brain injury. , Veterans of recent military conflicts in ...
(Date:3/3/2014)... Myriad Genetics, Inc. (Nasdaq: MYGN) today announced that ... in the journal Current Medical Research and Opinion ... original treatment plans for men with prostate cancer based ... a 46-gene molecular diagnostic test that has been evaluated ... , "Prolaris is an absolute game ...
(Date:3/2/2014)... of the Amur cork tree ( Phellodendron amurense ) ... Now it is being put through its paces by ... potential to make inroads against several more. , UT ... exploring the cork tree extract,s promise in treating prostate ... share some similar development pathways with prostate tumors. , ...
Breaking Medicine News(10 mins):Health News:New program for students with autism offers hope after high school 2Health News:Novel cancer vaccine holds promise against ovarian cancer, mesothelioma 2Health News:Novel cancer vaccine holds promise against ovarian cancer, mesothelioma 3Health News:Blasts may cause brain injury even without symptoms 2Health News:Blasts may cause brain injury even without symptoms 3Health News:Myriad publishes clinical utility study for Prolaris 2Health News:Myriad publishes clinical utility study for Prolaris 3Health News:Ancient Chinese medicine put through its paces for pancreatic cancer 2
... cancer types, treatment needs to be much tougher than is ... -- Even if they,re very small (1 centimeter or less), ... and require maximum therapy, U.S. researchers say. , A team ... for women with HER2 positive (HER2+) and triple negative (HER2- ...
... Center for Biotechnology and Genomic Medicine has been selected to ... children involved in a worldwide study of the causes of ... the mammoth study that will eventually follow 8,000 at-risk babies ... blood every three months as they go. , The ...
... Dec. 17 Derma Sciences (OTC Bulletin,Board: DSCI), a ... selected Allen & Caron, Inc. as its agency for ... a period of strong growth due in part to ... as well as the,FDA clearance of our MEDIHONEY(TM) products, ...
... REDMOND, Wash., Dec. 17 Incisionless surgery is ... It is being,rapidly adopted by a wide variety ... over 700 StomaphyX(TM) and EsophyX(TM) procedures already,performed globally. ... obtained FDA clearance this year, over 50 U.S. ...
... 17, 2007A new American Cancer Society report estimates that ... and 7.6 million cancer deaths (about 20,000 cancer deaths ... the first-ever Global Cancer Facts & Figures, the latest ... & Figures publications. The report estimates that 5.4 million ...
... RIKEN SNP Research Center, collaborating with a team at ... a new genetic variation that affects a childs risk ... acute inflammation of the arteries throughout the body. ... to standard treatment, as well as the risk of ...
Cached Medicine News:Health News:Even Tiny Breast Tumors May Need Aggressive Treatment 2Health News:MCG selected as RNA laboratory for worldwide diabetes study 2Health News:Derma Sciences Inc Selects Allen & Caron for Investor Relations and Corporate Communications 2Health News:Derma Sciences Inc Selects Allen & Caron for Investor Relations and Corporate Communications 3Health News:EndoGastric Solutions Opens Three Training Centers to Keep Up with Demand from Surgeons Wanting to Learn StomaphyX(TM) Procedures 2Health News:EndoGastric Solutions Opens Three Training Centers to Keep Up with Demand from Surgeons Wanting to Learn StomaphyX(TM) Procedures 3Health News:EndoGastric Solutions Opens Three Training Centers to Keep Up with Demand from Surgeons Wanting to Learn StomaphyX(TM) Procedures 4Health News:New report estimates 12 million cancer deaths worldwide 2Health News:International research collaboration narrows focus on genetic cause of Kawasaki disease 2Health News:International research collaboration narrows focus on genetic cause of Kawasaki disease 3
(Date:1/15/2014)... , January 15, 2014 Shire plc ... has waived the Office of Fair Trading (OFT) approval condition ... shares of ViroPharma Incorporated (NASDAQ: VPHM).   As ... conditional on OFT approval, and Shire expects to complete the ... expiration time, subject to the satisfaction of all of the ...
(Date:1/15/2014)... , January 15, 2014 BreedIT ... the exclusive worldwide distributor of highly sophisticated agro-breeding solutions ... January 7, 2014, the Company,s board of directors appointed ... as its new member of the board. ... positions with Teva Pharmaceutical Industries Ltd (NYSE: ...
(Date:1/15/2014)... 15, 2014  In an unprecedented effort to curb the ... in ambulances and other transport vehicles, an advanced and portable ... by rescue personnel for the first time. ... coming in contact with these deadly pathogens, West ... the nation to begin sanitizing the interior surfaces of its ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Superbugs No Longer Ride In Rescue Vehicles 2
... Research & Development, LLC (JRD) announced today that it has ... Food and Drug Administration (FDA) seeking approval for the use ... the risk of (thrombotic) cardiovascular events in patients with Acute ... data from the pivotal Phase 3 ATLAS ACS 2 TIMI ...
... Md., Dec. 28, 2011 Some medical devices are ... include instruments used in surgery (like clamps and forceps), ... areas inside the body. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) ... to microscopic amounts of blood, body fluids, and tissue ...
Cached Medicine Technology:Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 2Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 3Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 4Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 5Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 6Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 7Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 8Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 9Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 10Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome 11FDA Consumer Health Information - FDA Targets Risks From Reused Medical Devices 2
Angled 45, 9mm from end, Longer design from bend to tip allows for easier placement of viscoelastic to all meridians, Dome shape, extra smooth tip...
Smaller diameter wire probes & olive shape tips provide easier insertion through the lacrimal sac, 35cm (14 in) long, ID- .30mm (.012in); OD- .64mm (.025 in). S.S. Probes: .40mm x 11cm (27 G x 4 1/4...
...
Pre-set guard for precise depth incision, bi-directional blade can cut left or right. 250 micron....
Medicine Products: